Rate My Professor Gayle Fischer

Professor Fischer's research encompasses the clinical presentation, management, quality of life impact, and treatment responses in conditions like vulval lichen sclerosus, lichen planus, and psoriasis. Key publications include 'The impact of vulval lichen sclerosus in young people: a call for better awareness, individualized maintenance plans and revised guidelines' (British Journal of Dermatology, 2024), 'Vulvovaginal lichen planus mimicking desquamative inflammatory vaginitis' (Australasian Journal of Dermatology, 2024), 'Adult Vulval Psoriasis: Clinical Presentation, Management and Complications' (2025), 'Erosive Lichen Planus Treated With Tofacitinib: A Case Series of 23 Patients' (Australasian Journal of Dermatology, 2025), 'Why do some patients with vulval lichen sclerosus on long-term topical corticosteroids develop squamous cell carcinoma?' (Australasian Journal of Dermatology, 2022), and 'Long-term Management of Adult Vulvar Lichen Sclerosus: Defining the Response to Clobetasol Propionate 0.05% in Remission Induction and Maintenance' (JAMA Dermatology). She co-authored the third edition of 'The Vulva: A Practical Handbook for Clinicians' (Cambridge University Press, 2023, with Jennifer Bradford), a key resource on vulval diseases, vulvo-vaginal pain, and vaginitis. Recognized with the Order of Australia Medal (OAM) for services to dermatology, she has also received the University of Sydney Strategic Educational Grant and a Scientific Research Award. Her contributions extend to clinical trials, such as the efficacy of deucravacitinib versus methotrexate in vulvovaginal lichen planus.